Search results
How Long Does it Take For Metformin to Work For Weight Loss?
MediaFeed via AOL· 6 days agoWhen you’re motivated to lose weight and taking steps to make it happen, you want results — fast....
Insulin may be a thing of the past thanks to this groundbreaking diabetes cure
BGR· 5 days agoDiabetes is one of the world’s biggest health problems, an illness that doesn’t have a cure. You can...
Britain considers offering Lilly weight-loss drug on better terms than Wegovy
Reuters· 8 hours agoIn its draft roadmap for Mounjaro, known chemically as tirzepatide and sold in the U.S. for weight...
Woman's Doctor: Research shows potential connection between Alzheimer's and diabetes
WBAL-TV Baltimore· 1 day agoDOCTOR, RESEARCHERS REPORT THAT EVIDENCE SUGGESTS TYPE TWO DIABETES COULD BE LINKED TO ALZHEIMER’S...
Clogged Arteries Can Play a Significant Role in Severe Heart Conditions—Here Are the Warning Signs...
Parade via Yahoo News· 9 hours ago“Because of the reduced blood flow to the heart muscle from this disease,” Dr. Yang says...thought...
Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancer
Daily Express· 8 hours agoWeight loss jabs such as Ozempic have “enormous potential” as a new weapon in the fight against...
AdventHealth-partnered study finds new potential use for Ozempic - Orlando Business Journal
The Business Journals· 5 days agoThe study tracked those with Type 2 diabetes and chronic kidney disease — a group at high risk "for...
Menopause Can up the Risk of Recurrent Yeast Infections — Ob/Gyn Shares 4 Tips That Can Help
Woman's World via Yahoo News· 12 hours ago“We know that diabetics have more yeast infections, especially those with uncontrolled diabetes,”...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 6 days agoAt 48 weeks, patients lost up to 24.2% of their body weight. Lilly is also testing Mounjaro's...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 1 day agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical firm said its experimental ...